ONKURE THERAPEUTICS INC-A (OKUR) Stock Income Statement
NASDAQ:OKUR • US68277Q1058
Current stock price
3.99 USD
-0.6 (-13.07%)
At close:
4 USD
+0.01 (+0.25%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 62.95M | 54.39M | 83.05M | 53.85M | 39.82M | |||
| Research and Development | 48.26M | 43.80M | 56.61M | 37.71M | 28.17M | |||
| Selling, General, and Administrative Expenses | 14.69M | 10.59M | 26.44M | 16.14M | 11.65M | |||
| Operating Income | -62.95M | -54.39M | -83.05M | -53.85M | -39.82M | |||
| Interest Income/Expense | 3.43M | 1.71M | N/A | N/A | N/A | |||
| Other Income/Expense | N/A | N/A | 5.67M | 1.89M | 50.00K | |||
| Income Before Taxes | -59.52M | -52.67M | -77.39M | -51.96M | -39.77M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -59.52M | -52.67M | -77.39M | -51.96M | -39.77M | |||
| EBITDA | -62.50M | -53.93M | -82.88M | -53.76M | -39.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.40 | -15.28 | -25.23 | -2.12 | -1.63 | |||
| Non GAAP EPS | -4.41 | -6.57 | -25.30 | -21.20 | -48.60 | |||
| Statistics | ||||||||
All data in USD